Pharma Exclusives Pressreleases
European Commission approves KYGEVVI®▼ (doxecitine and doxribtimine) as first and only treatment for Thymidine Kinase 2 Deficiency (TK2d)
Tuesday, March 31, 2026UCB Euronext Brussels UCB a global biopharmaceutical company today announced that the European Commission EC has granted marketing authorization under exceptional circumstances for KYGEVVI
Zealand Pharma Establishes U.S. Research Hub in Cambridge, Massachusetts to Expand Drug Discovery Capabilities and Accelerate Medicine Creation
Wednesday, March 25, 2026Zealand Pharma AS Nasdaq ZEAL CVRno a biotechnology company transforming the future of metabolic health today announced the establishment of a new research hub in Cambridge Massachusetts in the greater Boston area
Thermo Fisher Scientific Introduces New Laboratory Developed Test to Help Transplant Patients Receive the Right Dose of Critical Anti-Rejection Medication Sooner
Friday, February 27, 2026Thermo Fisher Scientific the world leader in serving science today announced the launch of the TacroType Pharmacogenetic Test a new laboratory developed test designed to help inform clinicians on dosing tacrolimus
Novo Nordisk and Vivtex partner to develop next-generation oral medicines for obesity and diabetes
Thursday, February 26, 2026Novo Nordisk and Vivtex Corporation today announced a partnership to develop nextgeneration oral biologic medicines for obesity diabetes and associated comorbidities
Hansa Biopharma’s Biologics License Application (BLA) for imlifidase accepted by the FDA
Thursday, February 19, 2026Hansa Biopharma AB Hansa or the Company Nasdaq Stockholm HNSA today announced that its Biologics License Application BLA for imlifidase has been accepted by the US Food and Drug Administration FDA
LEON and Harro Höfliger Announce Strategic Collaboration for Global Distribution and After-Sales Service of Nanoencapsulation Equipment
Thursday, February 19, 2026Leonnanodrugs GmbH LEON a leading developer of advanced nanoencapsulation technology and equipment and Harro Hfliger a global expert in pharmaceutical engineering and GMPcompliant production
BioMed X Advances Women’s Health Innovation at Inaugural XFem Labs Pitch & Connect Event
Tuesday, February 17, 2026BioMed X a leading innovation hub for pharma headquartered in Heidelberg hosted the first XFem Labs Pitch Connect event on February th in Heidelberg marking the official launch of XFem Labs its new Womens Health RD Accelerator
Aspect Biosystems and Novo Nordisk enter new phase of partnership to develop curative medicines for diabetes
Wednesday, January 21, 2026Novo Nordisk and Aspect Biosystems today announced they are entering a new phase of their partnership to develop advanced cellular medicines for diabetes
Zealand Pharma enters agreement with DCAI to use Gefion AI supercomputer to accelerate drug discovery and support Metabolic Frontier 2030 strategy
Friday, January 09, 2026Zealand Pharma AS a biotechnology company transforming the future of metabolic health today announces an agreement with DCAI an AI infrastructure company which operates Gefion Denmarks supercomputer to strengthen and accelerate drug discovery
Novo Nordisk A/S: Wegovy® pill approved in the US as first oral GLP-1 for weight management
Tuesday, December 23, 2025Novo Nordisk today announced that the US Food and Drug Administration FDA has approved the Wegovy pill oncedaily oral semaglutide mg to reduce excess body weight and maintain weight reduction
